{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:02:23Z","timestamp":1789794143349,"version":"4.0.1"},"reference-count":14,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2026,9,30]]},"DOI":"10.7883\/yoken.jjid.2025.222","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:10:33Z","timestamp":1769724633000},"page":"214-217","source":"Crossref","is-referenced-by-count":0,"title":["Detection of Macrolide-Resistant &lt;i&gt;Mycoplasma Pneumoniae&lt;\/i&gt; in a Pediatric Primary and Secondary Emergency Care Center in Japan Following the COVID-19 Pandemic"],"prefix":"10.7883","volume":"79","author":[{"given":"Atsushi","family":"Miyake","sequence":"first","affiliation":[{"name":"Oita Children\u2019s Hospital, Japan"},{"name":"Department of Pediatrics and Child Health, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouki","family":"Ota","sequence":"additional","affiliation":[{"name":"Oita Children\u2019s Hospital, Japan"},{"name":"Department of Pediatrics and Child Health, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Gotoh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohito","family":"Okumiya","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Mizuochi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Kuga","sequence":"additional","affiliation":[{"name":"Oita Children\u2019s Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Wang K, Gill P, Perera R, et al. Clinical symptoms and signs for the diagnosis of <i>Mycoplasma pneumoniae<\/i> in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev. 2012;10:Cd009175.","DOI":"10.1002\/14651858.CD009175.pub2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kenri T, Suzuki M, Sekizuka T, et al. Periodic genotype shifts in clinically prevalent <i>Mycoplasma pneumoniae<\/i> strains in Japan. Front Cell Infect Microbiol. 2020;10:385.","DOI":"10.3389\/fcimb.2020.00385"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fukuda Y, Togashi A, Hirakawa S, et al. Changing patterns of infectious diseases among hospitalized children in Hokkaido, Japan, in the post\u2011COVID\u201119 era, July 2019 to June 2022. Pediatr Infect Dis J. 2023;42:766\u2011773.","DOI":"10.1097\/INF.0000000000003982"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Miyashita N, Ogata M, Fukuda N, et al. Macrolide\u2011resistant <i>Mycoplasma pneumoniae<\/i> infection prevalence increases again in Osaka. Respir Investig. 2025;63:517\u2011520.","DOI":"10.1016\/j.resinv.2025.04.009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide\u2011resistant <i>Mycoplasma pneumoniae<\/i> strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45:617\u2011620.","DOI":"10.1111\/j.1348-0421.2001.tb01293.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lucier TS, Heitzman K, Liu SK, et al. Transition mutations in the 23S rRNA of erythromycin\u2011resistant isolates of <i>Mycoplasma pneumoniae<\/i>. Antimicrob Agents Chemother. 1995;39:2770\u20112773.","DOI":"10.1128\/AAC.39.12.2770"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Zhou Y, Shan Y, Cui Y, et al. Characteristics and outcome of severe <i>Mycoplasma pneumoniae<\/i> pneumonia admitted to PICU in Shanghai: a retrospective cohort study. Crit Care Explor. 2021;3:e0366.","DOI":"10.1097\/CCE.0000000000000366"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Okada T, Morozumi M, Tajima T, et al. Rapid effectiveness of minocycline or doxycycline against macrolide\u2011resistant <i>Mycoplasma pneumoniae<\/i> infection in a 2011 outbreak among Japanese children. Clin Infect Dis. 2012;55:1642\u20111643.","DOI":"10.1093\/cid\/cis784"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Muto T, Nakamura N, Masuda Y, et al. Usefulness of Q\u2011Probe PCR in detecting macrolide\u2011resistant <i>Mycoplasma pneumoniae<\/i> infection in children. Jpn J Infect Dis. 2022;75:89\u201191.","DOI":"10.7883\/yoken.JJID.2021.003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nakamura Y, Oishi T, Kaneko K, et al. Recent acute reduction in macrolide\u2011resistant <i>Mycoplasma pneumoniae<\/i> infections among Japanese children. J Infect Chemother. 2021;27:271\u2011273.","DOI":"10.1016\/j.jiac.2020.10.007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sun Y, Li P, Jin R, et al. Characterizing the epidemiology of <i>Mycoplasma pneumoniae<\/i> infections in China in 2022\u20112024: a nationwide cross\u2011sectional study of over 1.6 million cases. Emerg Microbes Infect. 2025;14:2482703.","DOI":"10.1080\/22221751.2025.2482703"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lee JK, Lee JH, Lee H, et al. Clonal expansion of macrolide\u2011resistant sequence type 3 <i>Mycoplasma pneumoniae<\/i>, South Korea. Emerg Infect Dis. 2018;24:1465\u20111471.","DOI":"10.3201\/eid2408.180081"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pereyre S, Goret J, B\u00e9b\u00e9ar C. <i>Mycoplasma pneumoniae<\/i>: Current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7:974.","DOI":"10.3389\/fmicb.2016.00974"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Oishi T, Yoshioka D, Nakano T, et al. Recent trend of antimicrobial susceptibility among <i>Mycoplasma pneumoniae<\/i> isolated from Japanese children. Microorganisms. 2022;10.","DOI":"10.3390\/microorganisms10122428"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/79\/5\/79_JJID.2025.222\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:22:59Z","timestamp":1789791779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/79\/5\/79_JJID.2025.222\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2025.222","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"JJID.2025.222"}}